Quent Capital’s Zai Lab ZLAB Stock Holding History

Quent Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85K	Sell	150 -80	-35%	-$1.58K	﹤0.01%	1433
2026 Q1	$4.33K	Hold	230	–	–	﹤0.01%	1292
2025 Q4	$4.06K	Hold	230	–	–	﹤0.01%	1306
2025 Q3	$7.79K	Buy	+230	New	+$7.92K	﹤0.01%	1069
2025 Q2	–	Sell	-230	Closed	-$8.31K	–	1292
2025 Q1	$8.31K	Hold	230	–	–	﹤0.01%	934
2024 Q4	$6.02K	Hold	230	–	–	﹤0.01%	1008
2024 Q3	$5.55K	Hold	230	–	–	﹤0.01%	1084
2024 Q2	$3.99K	Buy	230 +125	+119%	+$2.2K	﹤0.01%	1120
2024 Q1	$1.68K	Hold	105	–	–	﹤0.01%	1249
2023 Q4	$2.87K	Hold	105	–	–	﹤0.01%	1160
2023 Q3	$2.55K	Sell	105 -1,354	-93%	-$36.1K	﹤0.01%	1153
2023 Q2	$40.5K	Buy	1,459 +59	+4%	+$1.93K	0.01%	639
2023 Q1	$47.2K	Buy	+1,400	New	+$53.7K	0.01%	616
2022 Q4	–	Sell	-12	Closed	–	–	1373
2022 Q3	$0	Hold	12	–	–	﹤0.01%	1288
2022 Q2	$0	Hold	12	–	–	﹤0.01%	1339
2022 Q1	$1K	Buy	+12	New	+$580	﹤0.01%	1238

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quent Capital's ZLAB Position: Q2 2026 in Review

Quent Capital reduced its Zai Lab (ZLAB) stake by 35% in Q2 2026, selling an estimated $1.58K and leaving 150 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Quent Capital first reported a position in ZLAB in Q1 2022 and has held it in 16 quarters since. The position peaked at $47.2K in Q1 2023. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

Quent Capital held 150 shares of Zai Lab worth $2.85K as of Q2 2026.
Quent Capital sold 80 Zai Lab shares in Q2 2026, an estimated $1.58K.
Zai Lab made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1433 holding.
Quent Capital first reported a position in Zai Lab in Q1 2022 and has held it in 16 quarters since.
Quent Capital's Zai Lab position peaked at $47.2K in Q1 2023.
93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.